Excellus BlueCross BlueShield Expands Its List of Covered Biosimilar Medications, Improving Access and Affordability
December 11, 2025
December 11, 2025
ROCHESTER, New York, Dec. 11 -- Excellus BlueCross BlueShield issued the following news release:
* * *
Excellus BlueCross BlueShield expands its list of covered biosimilar medications, improving access and affordability
Biosimilars for blockbuster autoimmune treatment, Stelara, added to list of covered drugs
*
A stark increase in the use and cost of specialty medications is challenging health insurers' affordability efforts n . . .
* * *
Excellus BlueCross BlueShield expands its list of covered biosimilar medications, improving access and affordability
Biosimilars for blockbuster autoimmune treatment, Stelara, added to list of covered drugs
*
A stark increase in the use and cost of specialty medications is challenging health insurers' affordability efforts n . . .
